Data on 137 Bone Marrow Transplant Patients
a data frame with 137 observations on the following 22 variables.
disease group; 1-ALL, 2-AML low-risk, 3-high-risk
time (in days) to death or on study time
disease-Free survival time (time to relapse, death or end of study)
death indicator; 1-Dead, 0-Alive
relapse indicator; 1-Relapsed, 0-Disease-Free
disease-Free survival indicator; 1-Dead or relapsed, 0-Alive disease-free
time (in days) to acute graft-versus-host disease
acute graft-versus-host disease indicator; 1-Developed acute graft-versus-host disease, 0-Never developed acute graft-versus-host disease
time (in days) to chronic graft-versus-host disease
chronic graft-versus-host disease indicator; 1-Developed chronic graft-versus-host disease, 0-Never developed chronic graft-versus-host disease
time (in days) to return of platelets to normal levels
platelet recovery indicator; 1-Platelets returned to normal levels, 0-Platelets never returned to normal levels
patient age in years
donor age in years
patient sex; 1-Male, 2-Female
donor sex; 1-Male, 2-Female
patient CMV status; 1-CMV positive, 0-CMV negative
donor CMV status; 1-CMV positive, 0-CMV negative
waiting time to transplant in days
FAB; 1-FAB Grade 4 or 5 and AML, 0-Otherwise
hospital; 1-The Ohio State University, 2-Alfred, 3-St. Vincent, 4-Hahnemann
MTX used as a graft-versus-host-prophylactic; 1-Yes, 0-No
1. R package "
2. Klein, J. P. and Moeschberger M. L. (2005). Survival Analysis: Techniques for Censored and Truncated Data.
Klein, J. P. and Moeschberger M. L. (2005). Survival Analysis: Techniques for Censored and Truncated Data.